Triple Receptor Agonist Metabolic Peptide (RT)

RT is a next-generation triple-agonist research peptide designed to activate GLP-1, GIP, and glucagon receptors simultaneously. This unique multi-pathway mechanism makes RT of significant interest in metabolic, weight-regulation and energy balance research models. Compared to singe or dual agonist incretin peptides, RT is studied for its potential to influence appetite signaling, insulin dynamics, and energy expenditure through coordinated receptor activity. This product is supplied as a 10mg lyophilized peptide intended strictly for laboratory research only. This peptide works on the incretin system, a gut derived hormonal signaling network that links food intake to insulin release, glucose control, appetite regulation and energy balance